| circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer Y Sang, B Chen, X Song, Y Li, Y Liang, D Han, N Zhang, H Zhang, Y Liu, ... Molecular Therapy 27 (9), 1638-1652, 2019 | 383 | 2019 |
| Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients X Kong, MS Moran, N Zhang, B Haffty, Q Yang European journal of cancer 47 (14), 2084-2090, 2011 | 321 | 2011 |
| LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215 X Kong, Y Duan, Y Sang, Y Li, H Zhang, Y Liang, Y Liu, N Zhang, Q Yang Journal of cellular physiology 234 (6), 9105-9117, 2019 | 256 | 2019 |
| MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin N Zhang, X Wang, Q Huo, M Sun, C Cai, Z Liu, G Hu, Q Yang Oncogene 33 (24), 3119-3128, 2014 | 192 | 2014 |
| Huaier aqueous extract inhibits proliferation of breast cancer cells by inducing apoptosis N Zhang, X Kong, S Yan, C Yuan, Q Yang Cancer science 101 (11), 2375-2383, 2010 | 170 | 2010 |
| SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2 N Zhang, H Zhang, Y Liu, P Su, J Zhang, X Wang, M Sun, B Chen, ... Cell Death & Differentiation 26 (5), 843-859, 2019 | 163 | 2019 |
| Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28 B Chen, Y Sang, X Song, D Zhang, L Wang, W Zhao, Y Liang, N Zhang, ... Theranostics 11 (8), 3932, 2021 | 157 | 2021 |
| circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer Y Liang, X Song, Y Li, P Su, D Han, T Ma, R Guo, B Chen, W Zhao, ... Oncogene 38 (42), 6850-6866, 2019 | 127 | 2019 |
| Epigenetic Regulation of NAMPT by NAMPT-ASDrives Metastatic Progression in Triple-Negative Breast Cancer H Zhang, N Zhang, Y Liu, P Su, Y Liang, Y Li, X Wang, T Chen, X Song, ... Cancer research 79 (13), 3347-3359, 2019 | 121 | 2019 |
| Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution T Sakurai, N Zhang, T Suzuma, T Umemura, G Yoshimura, T Sakurai, ... Medical Oncology 30, 1-7, 2013 | 102 | 2013 |
| Anti-angiogenic and antitumor activities of Huaier aqueous extract X Wang, N Zhang, Q Huo, Q Yang Oncology reports 28 (4), 1167-1175, 2012 | 99 | 2012 |
| DLC1-dependent parathyroid hormone–like hormone inhibition suppresses breast cancer bone metastasis Y Wang, R Lei, X Zhuang, N Zhang, H Pan, G Li, J Hu, X Pan, Q Tao, D Fu, ... The Journal of clinical investigation 124 (4), 1646-1659, 2014 | 95 | 2014 |
| CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR X Wang, T Chen, C Li, W Li, X Zhou, Y Li, D Luo, N Zhang, B Chen, ... Journal of hematology & oncology 15 (1), 122, 2022 | 92 | 2022 |
| The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis N Zhang, MS Moran, Q Huo, BG Haffty, Q Yang Cancer investigation 29 (9), 594-598, 2011 | 92 | 2011 |
| Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial–mesenchymal transition X Zhang, X Li, N Zhang, Q Yang, MS Moran Biochemical and biophysical research communications 412 (1), 188-192, 2011 | 87 | 2011 |
| Borderline ER-positive primary breast cancer gains no significant survival benefit from endocrine therapy: a systematic review and meta-analysis T Chen, N Zhang, MS Moran, P Su, BG Haffty, Q Yang Clinical breast cancer 18 (1), 1-8, 2018 | 81 | 2018 |
| Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis Q Huo, N Zhang, Q Yang PloS one 7 (2), e31656, 2012 | 81 | 2012 |
| Long noncoding RNA Linc00339 promotes triple‐negative breast cancer progression through miR‐377‐3p/HOXC6 signaling pathway X Wang, T Chen, Y Zhang, N Zhang, C Li, Y Li, Y Liu, H Zhang, W Zhao, ... Journal of Cellular Physiology 234 (8), 13303-13317, 2019 | 79 | 2019 |
| Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer Y Liang, Y Li, X Song, N Zhang, Y Sang, H Zhang, Y Liu, B Chen, W Zhao, ... Cancer biology & therapy 19 (2), 120-131, 2018 | 75 | 2018 |
| CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation T Chen, X Wang, C Li, H Zhang, Y Liu, D Han, Y Li, Z Li, D Luo, N Zhang, ... Oncogene 40 (15), 2756-2771, 2021 | 73 | 2021 |
